- Quantum BioPharma (NASDAQ:QNTM): FY Cash and cash equivalents totaled $12.1 million USD as of December 31, 2024, compared to $11.1 million USD as of December 31, 2023.
- The company’s strong balance sheet and overall progress enabled it to remove its Material
Quantum BioPharma reports FY results
